Rohm and Haas to increase prices

• Publisher: Elsevier Science
• Year: 2003
• Weight: 31 KB
• Volume: 2003
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(03)00428-8

✦ Synopsis

R&D costs rose by 5% to DKR 713 M for 2002. The group generated profit of DKR 644 M after tax for 2002. Headquartered in Denmark, Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical areas.